Atopic Dermatitis / Eczema Clinical Trial
Official title:
An Open Label, In-use Tolerance Study in Babies and Children With Dry/Atopic and Very Dry/Atopic Skin, to Evaluate the Acceptability and Skin Tolerability of E45 Eczema Repair Emollient for the Treatment of Atopic or Eczema Prone Skin
The investigation will evaluate, under dermatological control, the cutaneous in-use tolerance of E45 Eczema Repair Emollient with two or three times daily application, over a period of two weeks on children and babies with dry/atopic and very dry/atopic skin.
The investigation is an open label, in-use cutaneous tolerance investigation in children and
babies with dry/atopic and very dry/atopic skin, to evaluate the acceptability and skin
tolerability of E45 Eczema Repair Emollient.
The investigation will be an 'at home' user investigation where the test product will be
applied by the parent/legal guardian to a pre-defined test site (arm or leg) between 2 to 3
times daily, consecutively for 14 days.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04246372 -
Tofacitinib for Immune Skin Conditions in Down Syndrome
|
Phase 2 |